Vir Biotechnology Inc (VIR) is trading -6% lower at $29.17 today.

Vir Biotechnology Inc has been trading between a 52-week high of $58 and a 52-week low of $18.21. The stock has a market cap of $3.86 Billion.

Vir Biotechnology is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of product candidates targeting SARS-CoV-2, hepatitis B virus, influenza A, human immunodeficiency virus and tuberculosis.

Vir Biotechnology Stock Joins Rank Of Stocks With RS Ratings Over 90
Investor''s Business Daily 07-11-22

Brii Biosciences Exercises Option for Vir Biotechnology''s VIR-3434, a Broadly Neutralizing Monoclonal Antibody Targeting Hepatitis B in Greater China
PR Newswire Asia (English) 07-03-22

Vir Biotechnology Inc.’s (NASDAQ:VIR) Stock Is Up 7.29%, But Is It Capable Of A Rally?
Stocks Register 06-28-22

Vir Biotechnology reports data from Hepatitis B program
Seeking Alpha 06-27-22

Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program
GlobeNewswire 06-25-22